Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
30
2026

How 2026 Code Changes Shifted SRT from Sensus Healthcare to a Standard Treatment Option

For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…

April
24
2020

Zoom Meeting Recording: Skin Cancer Awareness Month & Treatment During COVID-19

Thank you to all of those who attended our second Zoom meeting discussing Skin Cancer Awareness month and treating patients during COVID-19. Our CEO, founder, and chairman Joe Sardano was joined by Dr. Ellen Turner,…

April
03
2020

The Prevalence of Basal Cell Carcinoma and the SRT-100™

Every year in the United States, there are more new cases of skin cancer than the year before. In fact, there are more new cases of skin cancer than breast, prostate, lung, and colon cancers…

March
27
2020

SRT Therapy with the SRT-100™: The Future of Keloid Treatment

In the 1980s, Superficial Radio Therapy was becoming a less popular option for keloid treatment due to the absence of any significant improvements in the technology, and equipment around the country was falling apart. Jump…

March
20
2020

SRT-100™: The Best Option for Treatment of Non-Melanoma Basal Cell Cancer

If you have been diagnosed with skin cancer, you are not alone. Skin cancer is one of the most commonly occurring forms of cancer, with more than one in every three new cancers diagnosed as…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry